Dr. Daniel H. Barnett
Claim this profileCarle Cancer Center
Studies Brain Tumor
Studies Renal Cell Carcinoma
11 reported clinical trials
40 drugs studied
Affiliated Hospitals
Clinical Trials Daniel H. Barnett is currently running
Stereotactic Radiosurgery vs. HA-WBRT + Memantine
for Brain Cancer
Stereotactic radiosurgery (SRS) is a commonly used treatment for brain tumors. It is a one-day (or in some cases two day), out-patient procedure during which a high dose of radiation is delivered to small spots in the brain while excluding the surrounding normal brain. Whole brain radiation therapy with hippocampal avoidance (HA-WBRT) is when radiation therapy is given to the whole brain, while trying to decrease the amount of radiation that is delivered to the area of the hippocampus. The hippocampus is a brain structure that is important for memory. Memantine is a drug that is given to help relieve symptoms that can be caused by WBRT, including problems with memory and other mental symptoms. Health Canada, the regulatory body that oversees the use of drugs in Canada, has not approved the sale or use of memantine in combination with WBRT to treat this kind of cancer, although they have allowed its use in this study.
Recruiting2 awards Phase 3
Radiation + Immunotherapy
for Head and Neck Cancer
This phase III trial compares pembrolizumab with radiation therapy to pembrolizumab without radiation therapy (standard therapy) given after pembrolizumab plus chemotherapy for the treatment of patients with squamous cell carcinoma of the head and neck that has spread from where it first started (primary site) to other places in the body (metastatic). Pembrolizumab is a type of immunotherapy that stimulates the body's immune system to fight cancer cells. Pembrolizumab targets and blocks a protein called PD-1 on the surface of certain immune cells called T-cells. Blocking PD-1 triggers the T-cells to find and kill cancer cells. Radiation therapy uses high-powered rays to kill cancer cells. Giving radiation with pembrolizumab may be more effective at treating patients with metastatic head and neck cancer than the standard therapy of giving pembrolizumab alone.
Recruiting2 awards Phase 327 criteria
More about Daniel H. Barnett
Clinical Trial Related6 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Daniel H. Barnett has experience with
- Pembrolizumab
- Stereotactic Ablative Radiotherapy
- Radiation Therapy
- Nivolumab
- Axitinib
- Cabozantinib
Breakdown of trials Daniel H. Barnett has run
Brain Tumor
Renal Cell Carcinoma
Kidney Cancer
Brain Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel H. Barnett specialize in?
Daniel H. Barnett focuses on Brain Tumor and Renal Cell Carcinoma. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are undergoing treatment.
Is Daniel H. Barnett currently recruiting for clinical trials?
Yes, Daniel H. Barnett is currently recruiting for 4 clinical trials in Urbana Illinois. If you're interested in participating, you should apply.
Are there any treatments that Daniel H. Barnett has studied deeply?
Yes, Daniel H. Barnett has studied treatments such as Pembrolizumab, Stereotactic Ablative Radiotherapy, Radiation Therapy.
What is the best way to schedule an appointment with Daniel H. Barnett?
Apply for one of the trials that Daniel H. Barnett is conducting.
What is the office address of Daniel H. Barnett?
The office of Daniel H. Barnett is located at: Carle Cancer Center, Urbana, Illinois 61801 United States. This is the address for their practice at the Carle Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.